
Optimizing Therapy in HR+/HER2+ Breast Cancer: Balancing Endocrine, HER2-Targeted, and Chemotherapy Options
Video content above is prompted by the following: Treatment Strategies for Triple-Positive Breast Cancer Panel Introduction Moderators and Panelists: Dr Kelly McCann, MD, PhD - Breast medical oncologist and assistant professor at the David Geffen School of …